With the financing being conducted through that of Tetra Bio-Pharma’s subsidiary, 2714140 Ontario Inc, no details were provided on the financing itself. It’s unclear what portion of the company Tetra would maintain should the full debenture be converted into equity into the currently wholly owned subsidiary. Tetra maintained that 2714140 Ontario Inc remains a fully owned subsidiary of the firm
...more